ZYNE had a 46% improvement with their CBD topical
Post# of 15624
(Total Views: 655)
Posted On: 09/28/2017 6:04:48 PM
ZYNE had a 46% improvement with their CBD topical gel for infants in their Phase II exploratory clinical trial of 20 patients. It is a synthetic CBD analogue. Their stock rose over 52% on this news. Our cream has shown a 70% improvement for inflammatory markers in psoriasis for our Phase I trial. Just wait until we publish our results. Hold on to your hats folks.
https://seekingalpha.com/news/3298091-zynerba...96-percent
https://seekingalpha.com/news/3298091-zynerba...96-percent
(1)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼